You can wear a patch to quit smoking, a patch to fend of pregnancy, and pretty soon, youll be able to wear a patch to treat depression.
Emsam, an experimental skin patch received U.S. regulatory approval for treating major depression in adults, Somerset Pharmaceuticals Inc. and Bristol-Myers Squibb announced on Tuesday.
The patch transmits monoamine oxidase inhibitors, a type of antidepressant, through the skin. These types of drugs have been approved by the FDA and carry warnings about risks...
Read moreWhat do you do if this happens: you get yourself together and not only make an appointment with a doctor to get your depression treated,... Read more »
Yesterday I started doing my yoga again. I know it’s hard to believe, but with a couple of Web sites, a 3-year-old son, multiple... Read more »
I think I've come up with a great way to save money on medical bills. Let's face it, they can be ridiculously high, and not everything is... Read more »
When we moved from Connecticut to California over a year ago, I had to end therapy with the therapist I had there. (I really liked her, but... Read more »
I am suffering from extreme chronic depression and panic disorder. Can Xanax and Klonopin help? Have other people experienced added... Read more »
Depression treatment often incorporates anti-depressant medicine and psychotherapy. Psychotherapy alone, involving cognitive and behavioral awareness... Read more »
The FDA has approved EMSAM (selegiline), a transdermal patch, for the treatment of major depression. Selegeline is a MAOI originally used to treat... Read more »
Scientists at Yale are working to develop ketamine--a drug used in party circles under the name "Special K"-- into a powerful and effective ... Read more »
A new study published in the Science Translational Medicine journal suggests that gene therapy may help ease depression. Researchers working with... Read more »
According to statistics, 80 percent of people who suffer from depression are treated by primary care physicians, many of whom work under the... Read more »